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Strengths and limitations of this study
 ► Population-based registry study including vast data 
from five countries, which will allow for greater gen-
eralisability than usual.
 ► The use of observational data (register) has the ad-
vantage of being less sensitive to study selection 
and allow for long-term follow-up.
 ► Multidisciplinary research with focus on medical, 
social and public health as well as health economics.
 ► Users and stakeholders are highly involved with the 
research.
 ► Application of advanced methods to reduce bias 
from unobservable factors and allow causal 
interpretation.
AbStrACt
Introduction Cerebral palsy (CP) is one of the most common 
neurodevelopmental disabilities. Yet, most individuals with CP 
are adults. How individuals with CP fare in terms of health, 
quality of life (QoL), education, employment and income is 
largely unknown. Further, little is known about the effects of 
having a child with CP on the parents. The Nordic countries 
are known for their strong welfare systems, yet it is unknown 
to what extent the added burden related to disability is 
actually compensated for. We will explore how living with 
CP affects health, QoL, healthcare utilisation, education, 
labour market outcomes, socioeconomic status and 
mortality throughout the lifespan of individuals with CP and 
their parents. We will also investigate if these effects differ 
between subgroups, within and across the Nordic countries.
Methods and analyses CP-North is a multidisciplinary 
4-year (1 August 2017 to 31 July 2021) register research 
project. The research consortium comprises researchers 
and users from Sweden, Norway, Denmark, Iceland 
and Finland. Data from CP registries and follow-up 
programmes, or cohorts of individuals with CP, will be 
merged with general national registries. All individual 
studies are structured under three themes: medical 
outcomes, social and public health outcomes, and health 
economics. Both case–control and cohort designs will be 
included depending on the particular research question. 
Data will be analysed in the individual countries and later 
merged across nations.
Ethics and dissemination The ethics approval processes 
in each individual country are followed. Findings will be 
published (open access) in international peer-reviewed 
journals in related fields. Updates on CP-North will be 
published online at http:// rdi. arcada. fi/ cpnorth/ en/
IntroduCtIon
Living with a disability does not need to be 
a negative experience. However, moving 
through life for individuals with disabilities 
is generally a different experience. How indi-
viduals with disabilities and their families fare 
in domains such as health, education and 
employment depends on a multitude of factors 
including type and severity of disability.1 2 Yet, 
life does not occur in a vacuum and as empha-
sised in the International Classification of Func-
tioning, Disability and Health outcomes related 
to activity and participation at different life 
arenas are greatly influenced by the interac-
tions among body functions and structure, 
personal factors and environmental factors 
such as family support, social and public 
health policies, medical interventions (and 
access to these), interpretation and enforce-
ment of laws, and societal attitudes.3 In their 
Report on Disability in 2011, the WHO and the 
World Bank outlined a number of domains 
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where globally, and as a group, individuals with disabili-
ties were at increased risk of adverse outcomes. According 
to this report, individuals with disabilities were some of 
the most marginalised in society with limited access to 
education, employment and financial resources.4 While 
it is likely that individuals with disabilities are worse off 
in some settings it has not been sufficiently studied how 
individuals with lifelong complex disabilities fare in other 
settings with privileges like universal healthcare and 
university education free of charge, such as in the Nordic 
countries (NC).
Cerebral palsy
To study ‘disability’ as a pooled heterogeneous group 
is justified at times,1 and in some cases there is as much 
heterogeneity within diagnoses as between. However, it is 
not always appropriate because certain disabilities mani-
fest so differently that the short and long-term ramifica-
tions vastly differ for the individuals and their families. At 
a prevalence of 2–3 per 1000 live births,5 6 cerebral palsy 
(CP) is one of the more common early-onset disabilities. 
CP is lifelong and associated with painful and progressive 
musculoskeletal complications and reduced participa-
tion in society.7–9 Studies on CP have not shown large sex 
differences, although the number of males with a diag-
nosis of CP is slightly higher, and there are no known 
sex differences on gross motor function.10 11 The causal 
brain damage is non-progressive, however, many asso-
ciated secondary conditions, which per definition are 
preventable, develop and worsen over time.12 Levels of 
function and comorbidities vary greatly; some individuals 
with CP function independently, whereas others experi-
ence severe limitations and require full-time assistance. 
Numerous treatments and medical procedures are used 
to maximise physical function such as physical and occu-
pational therapies, orthoses, medications and ortho-
paedic surgeries.
Little is known about the effects of CP on social and 
health economic outcomes. Knowledge is scarce also 
regarding medical outcomes, particularly in the long 
term for adults with CP. Some challenges associated with 
complex disabilities are shared virtually globally. Transi-
tions from childhood to adulthood and from paediatric to 
adult healthcare are examples of such challenges.13 The 
tradition of a well cared for paediatric population that 
‘age out’ of childhood in the late teens into uncharted 
territories in adulthood is a problem in many parts of the 
world, including the NC. In childhood, multidisciplinary 
clinics or habilitation units with broad expertise is the 
predominant model to treat and monitor complex condi-
tions, with school and family providing social scaffolding 
outside of the medical world. The same cohesive level of 
care and expertise are generally not available in adult-
hood, and it is startling how little is known about adults 
with CP.14 While certain medical centres, educational 
settings and workplaces are experienced in how to treat 
and include individuals with CP, many such places cluster 
in specific geographical regions. Varied outcomes within 
and across geographical regions might reflect differences 
in infrastructures, interpretation of policies and laws, or 
procedures that need to be modified. From a societal 
standpoint, this is important in determining how inter-
ventions and services should be prioritised, organised 
and implemented.
To have an income and be self-supporting are goals for 
most people. Despite ambitious political efforts and inte-
gration policies, individuals with disabilities still do not 
have the same access to work life as their peers without 
disabilities, irrespective of the severity of the disability.5 
Only around 10% of individuals with disabilities in 
Sweden who receive social services have a connection with 
or experience from the labour market.15 In Norway, 43% 
of individuals with disabilities have been reported to be 
employed, compared with 74% in the total population.16
Research shows that people with disabilities are more 
likely to be poor and to find it challenging to survive on 
a disability pension than those without a disability. Finan-
cial and social struggles create insecurity, anxiety and 
stress which are associated with negative physical and 
psychological health.17 18 Healthcare and social systems 
are under financial strain and to learn from each other 
in terms of what has worked—and importantly, what has 
not—as far as including individuals with disability in the 
labour market can facilitate sustainability of health and 
social systems.
Parents of individuals with CP
The implications of caring for a child with severe CP can 
be far reaching. In contrast to parents of typically devel-
oping children (TDC) the caretaking might become a 
lifelong commitment and implies extended care respon-
sibilities that parents of TDC are generally not exposed 
to. Parents of children with CP have been found more 
likely to struggle financially and to report higher levels 
of stress and depression than their counterparts with 
TDC.19–23 Being a close relative to someone with a serious 
health problem (eg, Alzheimer’s disease) is associated 
with reduced health, lower quality of life (QoL) and 
reduced labour market income.24 25 Similar findings 
have been observed in small non-Nordic studies on CP. 
It is not clear if this is the case in the context of the NC, 
where governmental benefits and support (to different 
degrees) are available for those with eligible diagnoses 
and their families to financially compensate and facilitate 
continued work attachment. The physical and emotional 
demands, as well as the logistical complexities of taking 
care of family members with multifaceted disabilities can 
be multiple. Anxiety regarding the children’s health and 
well-being, bureaucracy or full-blown battles to receive 
support, worries over how to cover steep out-of-pocket 
expenditures and concerns about what the future will 
hold for their children can put significant strain on the 
entire family units. Moreover, parents may be affected 
differently. Mothers are more likely than fathers to take 
parental leave and to stay home from work when children 
are ill. This might have a spillover effect in that mothers 
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might be more likely to reduce their work hours to care 
for their children with CP.26 Children with CP undergo 
many surgeries, which require a parent to stay home 
during the recovery period. Absence from the workforce, 
even for shorter periods, affects salary, opportunities for 
promotion and retirement benefits. Whereas parents of 
TDC might stay home or reduce their workload in the 
first and second years of their children’s lives, children 
with highly involved CP need extra involvement from 
the parents for years on end, if not for life. This affects 
parents financially and we hypothesise that mothers are 
disproportionally affected. The response of society and 
the extent to which social security compensates for loss of 
income and keeps the household out of financial insecu-
rity and poverty is important, but also how this response 
is distributed across the population. Potential inequalities 
in access to and levels of disability-related benefits as well 
as differences in exposure to financial deprivation will be 
studied herein as well as differences in these across the 
NC.
objectives
The overall purpose of CP-North is to explore how individ-
uals with CP, and their parents, are affected at the indi-
vidual, family and societal levels. Areas of study include 
how living with CP affects health, QoL, healthcare utilisa-
tion, medical intervention outcomes, education, labour 
market outcomes, socioeconomic status and mortality 
throughout the lifespan, and how outcomes differ based 
on disability-specific factors (eg, severity), personal factors 
(eg, sex), socioeconomic status and environmental factors 
(eg, geographical regions, policies).
The specific aims are to investigate the following:
1. What are the effects of CP on education, employment 
and income, and how do disability-specific factors 
such as degree/severity and comorbidity affect the 
outcomes
A. For adults with CP?
B. For parents of children with CP?
2. How, and to what degree, do social/disability-specific 
programmes and benefits offset economic vulnerabili-
ty in the case of CP
A. For adults with CP?
B. For parents of children with CP?
3. Are the disability-specific benefits equally distributed 
in relation to disability-specific functioning, demo-
graphics (eg, sex, age, region of residence) and socio-
economic status?
4. What are the effects of severe permanent disability 
(CP) in terms of health (eg, pain, medical complica-
tions, utilisation of drugs and healthcare), QoL and 
mortality
A. For children with CP?
B. For adults with CP?
C. For parents of children with CP?
5. Are there strategies of secondary prevention to reduce 
secondary conditions (eg, hip dislocations, scoliosis, 
fixed joint contractures) and to maximise health and 
function in individuals with CP in the NC, and are 
these associated with improved outcomes (eg, reduced 
pain, increased QoL)? What are the strategies?
6. Do patterns of healthcare contacts change over time? 
Is there a shift from preventive, planned care to more 
unplanned acute care as adolescents with severe dis-
abilities ‘grow out’ of the paediatric healthcare system? 
If so, is this related to higher healthcare costs and re-
duced (worse) health outcomes?
MEthodS
CP-North is a 4-year (1 August 2017 to 31 July 2021) 
population-based, multidisciplinary project consisting 
of cross-sectional and longitudinal registry studies in 
Sweden, Norway, Denmark, Finland and Iceland. The 
research in Iceland has been somewhat postponed, and 
Iceland will join the project later. However, the infor-
mation on Iceland is included in this research protocol. 
The research consortium consists of researchers and 
clinicians with broad areas of expertise including phys-
iotherapy, orthopaedics, psychology, health economics, 
public health and paediatrics. Secondary analyses will 
be performed on pre-existing data available in national 
quality registries (or cohorts) on CP and general national 
registers. Both case–control and cohort designs will be 
included depending on the particular research question. 
The five countries differ in how the healthcare is struc-
tured for individuals with CP: Sweden, Norway, Denmark 
and, to some extent, Iceland use similar systematic 
follow-up programmes, whereas Finland does not.
CP-North comprised numerous studies and it is beyond 
the scope of this protocol to provide details of each indi-
vidual study. In line with the purpose and aims, the work 
has been divided into three main themes: (1) medical 
outcomes, (2) social and public health outcomes, and (3) 
health economics. Each theme has an assigned research 
team dedicated to carry out the work entailed. During the 
first 2 years focus will primarily be on individual national 
studies, and in the final 2 years more collaborative studies 
across countries will be undertaken, at which time data 
will be pooled across countries.
Patient and public involvement
A reference team which comprised users and family 
members will provide input and feedback throughout 
the project. An Icelandic researcher heads the reference 
team; however, users from all five countries participate 
in the reference team. This research protocol includes 
input from users, who specifically highlighted the need 
for research on pain, family members and transition.
national quality registries and cohorts included
The Cerebral Palsy Follow-Up Program (CPUP) orig-
inated in Sweden in 1994. As a secondary prevention 
programme used by the habilitation services, CPUP was 
mainly designed to detect and treat early signs of musculo-
skeletal deterioration.27 The healthcare delivery model is 
coordinated across professional disciplines and includes 
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Figure 1 Follow-up schedule by physical therapists (PT) 
and occupational therapists (OT). GMFCS, Gross Motor 
Function Classification System.
orthopaedic surgeons, hand surgeons, physical therapists 
(PT), occupational therapists (OT), psychologists and 
neuropaediatricians. Other professionals are involved on 
an ‘as needed’ basis. In 2005, CPUP became a national 
quality registry, nationwide data collection was initiated 
and CPUP has served as a dual follow-up programme 
and registry ever since. Data are routinely collected on 
a number of variables such as gross motor function, 
mobility, hand function, range of motion, degree of spas-
ticity, hip displacement, pain and scoliosis (see www. cpup. 
se for a complete list). Gross motor function is classified 
using the Gross Motor Function Classification System 
Expanded & Revised Version (referred to as GMFCS in 
this report), which replaced the original GMFCS system 
in 2007 and expanded the age range to also include 12–18 
year-olds.28 The GMFCS is a five-level classification system 
that describes gross motor function of children and youth 
with CP based on gross motor performance in daily life.29 
GMFCS V indicates more severely affected gross motor 
function whereas GMFCS I indicates the least affected 
gross motor function. Similarly, the Manual Ability Clas-
sification System is used to classify manual abilities, and 
more recently, the Communication Function Classifica-
tion System has been included to classify communica-
tion.29 Adults with CP are eligible to participate; however, 
the adult cohort in CPUP does not comprise the total 
population. The assessment schedules differ based on 
GMFCS level and age, and based on those parameters 
CPUP assessments are recommended annually or bian-
nually (figure 1).
The Cerebral Palsy Registry of Norway (CPRN) is a 
consent-based national medical quality registry that has 
systematically recorded detailed clinical information on 
all children with CP in Norway born 1996 and onwards. 
The purpose of the registry is to collect data on children 
and youth with CP in Norway and to follow prevalence, 
specifically causes and risk factors, increase knowledge 
and monitor the status of treatments and habilitation, 
ensure systematic, equal and predictable follow-up of 
children and youth with CP, regardless where they live, 
and to suggest measures to improve treatments, function, 
QoL and participation. The CPRN registers children with 
CP at three stages: at the time of diagnosis, at 5 years and 
at 15–17 years of age. The completeness of the CPRN has 
been ascertained by linking the CPRN with the Norwe-
gian Patient Registry using the 11-digit personal identifi-
cation number unique to each resident in Norway.30
The Cerebral Palsy Follow-up Program (CPOP) was 
established as a project in South-eastern Norway in 2006, 
funded by the Norwegian Directorate of Health, and 
implemented nationally in 2010. CPOP uses the same 
protocol as CPUP, and works in close collaboration with 
CPRN. Multidisciplinary teams in 21 habilitation centres 
conduct the assessments of the children according to the 
CPOP protocol. For quality purposes, and to contribute 
to equal treatment nationwide, CPOP runs a network 
of local health professional coordinators in the habil-
itation centres and their collaborating municipalities. 
Together, CPRN and CPOP facilitate the identification 
of prevalence, causal pathways and the need for habilita-
tion interventions for all individuals with CP, and thereby 
contribute to the knowledge base needed to guide the 
prioritising of health services for individuals with CP and 
childhood-onset disabilities.27
The Danish CPOP, currently under development, 
also serves as a joint follow-up programme and national 
quality registry. It was developed to monitor and improve 
healthcare and QoL for children with CP. Similar to 
CPUP and CPOP-Norway, the children in the five regions 
included are offered systematic assessments by multidis-
ciplinary teams of professionals. Denmark differs from 
Sweden and Norway in that it does not use habilitation 
units. Children with CP are followed in hospitals by ortho-
paedic surgeons, hand surgeons and paediatric neurol-
ogists, PTs, OTs and psychologists throughout the 98 
municipalities. Six quality indicators are used based on 
radiographic examination of the hip, gross motor func-
tion, manual ability and diagnosis.31
Two institutions in Iceland, Æfingastöðin (since 2012) 
and Endurhæfing-þekkingarsetur (since 2014), offer their 
clients access to the Icelandic CP Follow-Up Program 
(CPEF). Æfingastöðin specialises in children and youth, 
whereas Endurhæfing-þekkingarsetur specialises in 
adults 18 years of age or older. Both institutions are in the 
capital area of Reykjavik, and only a small number of indi-
viduals from other regions in the country are included. 
CPEF is largely based on CPUP and the data are hosted 
on the same platform as CPUP in Sweden, which has been 
approved by the Icelandic Data Protection Authority. 
CPEF is not designated as a national quality registry. 
Recruitment to CPEF is underway and more individuals 
will be recruited, in particular during the first 2 years of 
CP-North.
Finland has no national CP registry and will serve as a 
comparison. For longitudinal follow-up, the 1987 National 
Birth Cohort will be used. The main purpose of the devel-
opment of this cohort was to study the impact of child-
hood on health and well-being later on in life. The cohort 
includes all children entered in the 1987 Medical Birth 
Registry, including all live births >500 g or a gestational 
age of >22 weeks.32 In total, the cohort includes over 60 
000 individuals of which 229 have CP. Birth data have 
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Table 1 National quality registries and cohorts included in CP-North
Sweden Norway Denmark Iceland Finland
CPUP
Children and 
adolescents aged 0–18 
years n=3700
Adults n=1000
CPRN
Children and 
adolescents aged 0–22 
years n=2350
Adults n=100
CPOP
Children and 
adolescents aged 0–16 
years n=1500
CPOP
Children and 
adolescents aged 0–15 
years n=761
CPEF
Children and 
adolescents aged 0–18 
years n=100
Adults n=100
1987 National Birth 
Cohort
Children and 
adolescents aged 0–25 
years
n=229
CPEF, Icelandic CP Follow-Up Program; CPRN, Cerebral Palsy Registry of Norway; CPUP/CPOP, Cerebral Palsy Follow-Up Program in 
Sweden and Norway, respectively.
been combined with data from several other registries, 
including data on social and socioeconomic status, health 
status and educational level of the cohort members and 
their parents.33 The cohort has been followed to the age 
of 25 years. Additionally, data from several different data-
bases will be used and combined to answer the research 
questions. To be able to answer research question 5, data 
from medical charts at two university hospitals will be 
collected. A summary of the national quality registries 
and cohorts included is summarised in table 1.
national registries
Data from CPUP/CPOP-CPRN/CPOP/CPEF and the 
Finnish 1987 cohort will be merged with data from 
national registries in the five countries. Individuals with 
diagnoses of CP (cases; International Classification of 
Diseases 10th Revision G80 code) will be identified in 
the respective national quality registries, when appli-
cable, and cross-referenced with the national registries 
that contain medical diagnoses (eg, national patient and 
medical birth registries) in the respective countries. A 
control group from the general population will be identi-
fied at a 5:1 ratio, matched on sex, birth year, country and 
municipality excluding any siblings to cases. The parents 
of the identified cases/controls will also be included using 
multigenerational registries. Staff at one of the national 
registries will perform the merging of data and the 
researchers in CP-North will only have access to unidenti-
fied matched data on the variables of interest. Examples 
of the registries to be used in the respective countries, as 
well as examples of variables that will be accessed from 
each registry are summarised in table 2.
Information from a number of national registries will 
be linked to the identified individuals (cases and controls 
including parents) using the unique personal identi-
fication numbers available in the NC. Using Swedish 
registries as an example (although corresponding and 
additional registries from other NCs will also be used), 
school performance will be linked from the Registry of 
Grades from mandatory and secondary school, labour 
market outcomes and social security benefits from the 
Longitudinal Integration Database for Health Insurance 
and Labour Market Studies, demographic information 
from the Registry of the Total Population, healthcare 
utilisation and medical diagnoses from the National 
Patient Registry, pregnancy-related factors from the 
Medical Birth Registry and mortality information from 
the Cause of Death Registry. Disability-specific infor-
mation for the cases will be extracted from CPUP (not 
available in Finland, where additional data collection 
will be necessary). Healthcare utilisation data will also be 
extracted from regional healthcare utilisation databases, 
which include more detailed information compared with 
the National Patient Registry (eg, healthcare episodes 
in primary care, costs and activity codes). To the extent 
possible, all identified persons will be followed from 1990 
(or birth) until 2015 (or death), that is, a maximum of 25 
years for each person.
All national registries have strict procedures that must 
be followed to access and use the data. These procedures 
pertain, for instance, to how the data must be stored and 
who can access them, which is also generally specified by 
the ethical review boards. The practical management of 
the data will be handled through the Nordic Microdata 
Access Network (NordMAN). NordMAN is an ongoing 
collaboration project between the Nordic National Statis-
tical Institutes to facilitate for researchers in applying for 
and accessing data from Nordic registries. The data will 
be managed, analysed, presented and archived in compli-
ance with national regulations, European Union direc-
tives (when applicable), Good Epidemiological Practice 
and the requirements posed by the ethical review boards.
data analysis plan and statistical considerations
In general, the data will be analysed using standard regres-
sion techniques such as ordinary least squares, logistic 
regressions and selection models. The maximum like-
lihood Heckman selection model will be used when it 
is only possible to observe an outcome for a restricted, 
non-random sample. This type of model is appropriate, 
for example, when estimating a healthcare cost equation 
where many observations generally have no healthcare 
visits during a specific time period, or when estimating 
a wage equation (wage is dependent on employment). 
Disability-specific factors will be used to identify the models. 
Additional regression techniques and estimation methods 
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Table 2 National registries to be used
Examples of registries to be used and examples of relevant variables in the registries
Sweden Norway Denmark Iceland Finland
Statistics Sweden (SCB)
LISA: employment, unemployment, 
absenteeism, income (eg, work 
income, pensions, benefits), 
education and immigration status.
Register of the Total Population: 
demographic information (eg, country 
of birth, region of residence).
Statistics Norway 
Demographic 
information, family 
relations, education.
FD-Trygd Work, income, 
social insurance and 
demographics.
Statistics Denmark
Information corresponding to the 
Swedish registers is available 
from Statistics Denmark although 
not organised into named 
registers.
Statistics Iceland
Tax register
Education registry
Registers Iceland
Benefits and allowances 
are available from the 
Social Insurance 
Administration.
Statistics Finland
Finnish Longitudinal Employer-
Employee Data (FLEED)
Causes of death
Benefits and allowances are 
available from the Social 
Insurance Institution (KELA), 
some also from the
National Institute of Health and 
Welfare.
Employment and pension are also 
available from the Finnish Centre 
for Pensions.
National Board of Health and 
Welfare
National Patient Register: frequency/
duration of inpatient care, ICD codes, 
number of healthcare visits and 
operation codes.
Cause of Death Registry:
dates and causes of death.
Norwegian Institute of 
Public Health
Norwegian Directorate 
of Health
Norwegian Patient 
Registry
Cause of Death Registry
Norwegian Neonatal 
Network
Medical Birth Registry of 
Norway
Sundhedsdatastyrelsen
Civil Registration System National 
Patient Registry
Register on Causes of Death
Cancer Registry
Psychiatric Central Research 
Register
Medical Birth Registry
The Directorate of 
Health
Birth registry
Causes of death registry
Inpatient care registry
Primary care visits 
registry
Specialists’ clinic registry
National Institute of Health and 
Welfare
Medical Birth Register
Care Register for Health Care
Register of Primary Health Care 
Visits (2011–)
Drug Registry: medical prescriptions 
and eligible supplies filled at the 
pharmacies and the associated costs.
The Norwegian 
Prescription Database
Lægemiddelstatistikregisteret The Directorate of 
Health and Icelandic 
Health Insurance
Drug Registry
KELA
Drug utilisation
County councils
Healthcare utilisation databases:
healthcare utilisation including 
diagnoses, activity codes and 
associated costs.
        
ICD, International Classification of Diseases.
that will be employed include regression discontinuity anal-
ysis, difference-in-difference estimations and fixed effects 
models, with the objective of estimating causal effects.
When studying the effects of CP on the parents of the 
individuals with CP it is plausible that parental factors are 
correlated both with the likelihood of the child having CP 
and parental outcomes. Causes of CP are often not known, 
nevertheless certain parental health-related behaviours 
are known to influence both parental outcomes and the 
risk of giving birth to a child with CP (mediated through, 
for example, prematurity and low birth weight). Socio-
economic factors, directly or indirectly, are associated 
with increased disease risk and future parental outcomes. 
Thus, standard regression techniques might produce 
biased results for parents.34 We will therefore control for 
the potential non-random selection using, for example, 
‘average treatment effect models’. Using propensity scores 
based on the estimated likelihood of giving birth to a child 
with CP, observable differences between the groups can be 
accounted for. These types of models can easily be extended 
to survival and time-to-event estimations.35 However, it is 
only possible to adjust for observed differences between 
groups and this is why it is necessary to have access to exten-
sive longitudinal data including medical, socioeconomic 
and demographic data.25 The statistical analyses will be 
performed using SAS, Stata and R.
EthICS And dISSEMInAtIon
Sweden, Norway and Finland have ethics approvals for the 
overall CP-North research programme (Sweden: Regional 
Ethics Board, Lund, 2018/1000; Norway: Regional 
Committees for Medical and Health Research Ethics 
2017/2457 REK sør-øst D; Finland: Helsinki Univer-
sity Hospital Ethical Committee IV (HUS 3640/2017)). 
The ethics review processes in Denmark differ for 
registry research and a waiver has been obtained. The 
approval from the Icelandic Bioethics Committee has 
been obtained (18-144). However, an approval from 
the Icelandic Data Protection Authority is still pending 
and is required before full approval can be granted. No 
research will be performed without the appropriate ethics 
approvals in the individual countries.
There will be an active dissemination throughout the 
whole project. A dissemination and communication team 
has been created with the purpose to plan and carry 
out the dissemination as planned. The overall goal is to 
disseminate the results of CP-North to a wide audience 
including the scientific audience and stakeholders (eg, 
persons with CP, their families and governmental agen-
cies), policymakers in the NC, healthcare administrators, 
the general public, user organisations as well as higher 
education students. Different tools will be used to dissem-
inate the process as well as results. Additionally, results 
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will be presented at meetings or in scientific journals 
related to CP, and at more generic meetings, workshops, 
webinars and public journals. Updates on CP-North will 
be published online at the CP-North website at http:// rdi. 
arcada. fi/ cpnorth/ en/
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